Novavax
NVAX
#5448
Rank
NZ$2.61 B
Marketcap
NZ$15.89
Share price
-3.89%
Change (1 day)
51.34%
Change (1 year)

Novavax (NVAX) - Net assets

Net assets on the balance sheet as of March 2026 : -NZ$0.26 Billion

According to Novavax's latest financial reports the company has -NZ$0.26 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novavax - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-NZ$0.23 Billion-80.06%
2024-12-31$-NZ$1.11 Billion-2.43%
2023-12-31$-NZ$1.14 Billion13.51%
2022-12-31$-NZ$1 Billion93.97%
2021-12-31$-NZ$0.52 Billion-159.23%
2020-12-31$NZ$0.86 B-414.72%
2019-12-31$-NZ$0.28 Billion10.32%
2018-12-31$-NZ$0.26 Billion74.78%
2017-12-31$-NZ$0.15 Billion1689.1%
2016-12-31$-NZ$8.01 Million-101.87%
2015-12-31$NZ$0.42 B45.91%
2014-12-31$NZ$0.29 B18.5%
2013-12-31$NZ$0.24 B153.55%
2012-12-31$NZ$97.53 M41.37%
2011-12-31$NZ$68.99 M-9.86%
2010-12-31$NZ$76.54 M-20.53%
2009-12-31$NZ$96.3 M22.87%
2008-12-31$NZ$78.38 M-4.79%
2007-12-31$NZ$82.33 M-38.3%
2006-12-31$NZ$0.13 B83.68%
2005-12-31$NZ$72.64 M55.75%
2004-12-31$NZ$46.64 M-15.65%
2003-12-31$NZ$55.29 M258.46%
2002-12-31$NZ$15.42 M-76.7%
2001-12-31$NZ$66.2 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
NZ$67.74 B-26,990.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$157.32 B-62,550.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$82.45 B-32,832.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$40.15 B-16,038.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$2.61 B-1,139.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$0.79 B-415.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-NZ$0.49 Billion 94.02%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ$12.48 M-104.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.97 Billion 282.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.01 B-502.38%๐Ÿ‡บ๐Ÿ‡ธ USA